{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:06:34Z","timestamp":1783638394301,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11606-022-07701-3","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T19:02:47Z","timestamp":1656529367000},"page":"4144-4152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans"],"prefix":"10.1007","volume":"37","author":[{"given":"Christine M.","family":"Hunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy T.","family":"Efird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"Thomas S.","family":"Redding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Andrew D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlyn M.","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Hostler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1824-1067","authenticated-orcid":false,"given":"Ayako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"issue":"2","key":"7701_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jama.2020.24865","volume":"325","author":"SH Woolf","year":"2021","unstructured":"Woolf SH, Chapman DA, Lee JH. COVID-19 as the leading cause of death in the United States. JAMA 2021;325(2):123-4.","journal-title":"JAMA"},{"issue":"5","key":"7701_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/M20-3012","volume":"173","author":"DP Oran","year":"2020","unstructured":"Oran DP. Prevalence of asymptomatic SARS-CoV-2 infection. Ann Intern Med 2020;173(5):362-7.","journal-title":"Ann Intern Med"},{"issue":"9","key":"7701_CR3","doi-asserted-by":"publisher","first-page":"e2022310-e","DOI":"10.1001\/jamanetworkopen.2020.22310","volume":"3","author":"GN Ioannou","year":"2020","unstructured":"Ioannou GN, Locke E, Green P, Berry K, O\u2019Hare AM, Shah JA, et al. Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US Veterans with SARS-CoV-2 infection. JAMA Network Open. 2020;3(9):e2022310-e.","journal-title":"JAMA Network Open"},{"key":"7701_CR4","doi-asserted-by":"crossref","unstructured":"Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and mortality among Black patients and White patients with Covid-19. N Engl J Med 2020;382(26):2534-43.","DOI":"10.1056\/NEJMsa2011686"},{"issue":"1","key":"7701_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/jamainternmed.2020.3857","volume":"181","author":"P Karaca-Mandic","year":"2021","unstructured":"Karaca-Mandic P, Georgiou A, Sen S. Assessment of COVID-19 hospitalizations by race\/ethnicity in 12 states. JAMA Intern Med 2021;181(1):131-4.","journal-title":"JAMA Intern Med"},{"issue":"8","key":"7701_CR6","first-page":"693","volume":"384","author":"Group RC","year":"2020","unstructured":"Group RC. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2020;384(8):693-704.","journal-title":"N Engl J Med"},{"key":"7701_CR7","doi-asserted-by":"publisher","unstructured":"Ioannou GN, O'Hare AM, Berry K, Fan VS, Crothers K, Eastment MC, et al. Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection. Clin Infect Dis. 2021;ciab419. https:\/\/doi.org\/10.1093\/cid\/ciab419.","DOI":"10.1093\/cid\/ciab419"},{"issue":"3","key":"7701_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jama.2020.21465","volume":"325","author":"JP Donnelly","year":"2021","unstructured":"Donnelly JP, Wang XQ, Iwashyna TJ, Prescott HC. Readmission and death after initial hospital discharge among patients with COVID-19 in a large multihospital system. JAMA. 2021;325(3):304-6.","journal-title":"JAMA."},{"issue":"24","key":"7701_CR9","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1001\/jama.2020.23422","volume":"324","author":"G Piazza","year":"2020","unstructured":"Piazza G, Morrow DA. Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19. JAMA. 2020;324(24):2548-9.","journal-title":"JAMA."},{"issue":"2","key":"7701_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","volume":"32","author":"X-J Zhang","year":"2020","unstructured":"Zhang X-J, Qin J-J, Cheng X, Shen L, Zhao Y-C, Yuan Y, et al. In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Meta. 2020;32(2):176-87.e4.","journal-title":"Cell Meta"},{"key":"7701_CR11","doi-asserted-by":"crossref","unstructured":"Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Network Open. 2020;3(12):e2029058-e.","DOI":"10.1001\/jamanetworkopen.2020.29058"},{"issue":"4","key":"7701_CR12","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jinf.2020.07.008","volume":"81","author":"R Rossotti","year":"2020","unstructured":"Rossotti R, Travi G, Ughi N, Corradin M, Baiguera C, Fumagalli R, et al. Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: a comparative analysis. J Infect 2020;81(4):e11-e7.","journal-title":"J Infect"},{"issue":"7","key":"7701_CR13","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1172\/JCI139642","volume":"130","author":"MF Konig","year":"2020","unstructured":"Konig MF, Powell M, Staedtke V, Bai R-Y, Thomas DL, Fischer N, et al. Preventing cytokine storm syndrome in COVID-19 using \u03b1-1 adrenergic receptor antagonists. J Clin Invest 2020;130(7):3345-3347.","journal-title":"J Clin Invest"},{"issue":"2","key":"7701_CR14","doi-asserted-by":"publisher","first-page":"e2037053","DOI":"10.1001\/jamanetworkopen.2020.37053","volume":"4","author":"RW Thomsen","year":"2021","unstructured":"Thomsen RW, Christiansen CF, Heide-J\u00f8rgensen U, Vogelstein JT, Vogelstein B, Bettegowda C, et al. Association of \u03b11-blocker receipt with 30-day mortality and risk of intensive care unit admission among adults hospitalized with influenza or pneumonia in Denmark. JAMA Netw Open 2021;4(2):e2037053.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"7701_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/jama.2020.13372","volume":"324","author":"S Bilaloglu","year":"2020","unstructured":"Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. JAMA. 2020: 324(8):799-801.","journal-title":"JAMA."},{"issue":"4","key":"7701_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1213\/ANE.0000000000005292","volume":"132","author":"JH Chow","year":"2021","unstructured":"Chow JH, Khanna AK, Kethireddy S, Yamane D, Levine A, Jackson AM, et al. Aspirin use is associated with decreased mechanical ventilation, ICU admission, and in-hospital mortality in hospitalized patients with COVID-19. Anesth Analg 2021;132(4):930-941.","journal-title":"Anesth Analg"},{"issue":"3","key":"7701_CR17","doi-asserted-by":"publisher","first-page":"e213594","DOI":"10.1001\/jamanetworkopen.2021.3594","volume":"4","author":"R Baral","year":"2021","unstructured":"Baral R, Tsampasian V, Debski M, Moran B, Garg P, Clark A, et al. Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis. JAMA Netw Open 2021;4(3):e213594.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"7701_CR18","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/s41467-021-21553-1","volume":"12","author":"A Gupta","year":"2021","unstructured":"Gupta A, Madhavan MV, Poterucha TJ, DeFilippis EM, Hennessey JA, Redfors B, et al. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nat Commun 2021;12(1):1325.","journal-title":"Nat Commun"},{"issue":"6521","key":"7701_CR19","doi-asserted-by":"publisher","first-page":"eabe9403","DOI":"10.1126\/science.abe9403","volume":"370","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Hiatt J, Bouhaddou M, Rezelj VV, Ulferts S, Braberg H, et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020:370(6521):eabe9403.","journal-title":"Science"},{"issue":"7","key":"7701_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/annrheumdis-2020-219517","volume":"80","author":"AY Wong","year":"2021","unstructured":"Wong AY, MacKenna B, Morton CE, Schultze A, Walker AJ, Bhaskaran K, et al. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis 2021;80(7):943-51.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7701_CR21","first-page":"469","volume":"288","author":"Z Imam","year":"2020","unstructured":"Imam Z, Odish F, Gill I, O'Connor D, Armstrong J, Vanood A, et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States J Intern Med 2020;288(4):469-76.","journal-title":"United States J Intern Med"},{"issue":"5","key":"7701_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S2213-8587(21)00050-4","volume":"9","author":"K Khunti","year":"2021","unstructured":"Khunti K, Knighton P, Zaccardi F, Bakhai C, Barron E, Holman N, et al. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol 2021;9(5):293-303.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7701_CR23","doi-asserted-by":"publisher","first-page":"108183","DOI":"10.1016\/j.diabres.2020.108183","volume":"164","author":"S Sharma","year":"2020","unstructured":"Sharma S, Ray A, Sadasivam B. Metformin in COVID-19: a possible role beyond diabetes. Diabetes Res Clin Pract 2020;164:108183.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"7701_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s40618-021-01614-4","volume":"45","author":"R Pal","year":"2021","unstructured":"Pal R, Banerjee M, Bhadada SK, Shetty AJ, Singh B, Vyas A. Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis. J Endocrinol Investig 2021;45(1):53-68.","journal-title":"J Endocrinol Investig"},{"issue":"8","key":"7701_CR25","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.annonc.2020.04.479","volume":"31","author":"M Montopoli","year":"2020","unstructured":"Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Ann Oncol 2020;31(8):1040-5.","journal-title":"Ann Oncol"},{"issue":"1","key":"7701_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.hjc.2020.03.002","volume":"61","author":"SG Deftereos","year":"2020","unstructured":"Deftereos SG, Siasos G, Giannopoulos G, Vrachatis DA, Angelidis C, Giotaki SG, et al. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design. Hell J Cardiol 2020;61(1):42-5.","journal-title":"Hell J Cardiol"},{"key":"7701_CR27","doi-asserted-by":"publisher","first-page":"101989","DOI":"10.1016\/j.pupt.2021.101989","volume":"67","author":"JI Mor\u00e1n Blanco","year":"2021","unstructured":"Mor\u00e1n Blanco JI, Alvarenga Bonilla JA, Homma S, Suzuki K, Fremont-Smith P, Villar G\u00f3mez de Las Heras K. Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - a retrospective observational study in elderly patients. Pulm Pharmacol Ther 2021;67:101989.","journal-title":"Pulm Pharmacol Ther"},{"issue":"16","key":"7701_CR28","doi-asserted-by":"publisher","first-page":"8486","DOI":"10.3390\/ijerph18168486","volume":"18","author":"A Suzuki","year":"2021","unstructured":"Suzuki A, Efird JT, Redding TSt, Thompson AD, Jr., Press AM, Williams CD, et al. COVID-19-associated mortality in US Veterans with and without SARS-CoV-2 infection. Int J Environ Res Public Health 2021;18(16):8486.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"7701_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1478-7954-4-2","volume":"4","author":"M-W Sohn","year":"2006","unstructured":"Sohn M-W, Arnold N, Maynard C, Hynes DM. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metrics 2006;4(1):2.","journal-title":"Popul Health Metrics"},{"issue":"279","key":"7701_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/01621459.1957.10501395","volume":"52","author":"WH Kruskal","year":"1957","unstructured":"Kruskal WH. Historical notes on the wilcoxon unpaired two-sample test. J Am Stat Assoc 1957;52(279):356-60.","journal-title":"J Am Stat Assoc"},{"key":"7701_CR31","first-page":"5","volume":"32","author":"NE Breslow","year":"1980","unstructured":"Breslow NE, Day NE. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ. 1980(32):5-338.","journal-title":"IARC Sci Publ."},{"issue":"4","key":"7701_CR32","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","volume":"75","author":"Y Hochberg","year":"1988","unstructured":"Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988;75(4):800-2.","journal-title":"Biometrika"},{"issue":"1","key":"7701_CR33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995;57(1):289-300.","journal-title":"J R Stat Soc Ser B Methodol"},{"issue":"469","key":"7701_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1198\/016214504000001907","volume":"100","author":"Y Benjamini","year":"2005","unstructured":"Benjamini Y, Yekutieli D. False Discovery rate\u2013adjusted multiple confidence intervals for selected parameters. J Am Stat Assoc 2005;100(469):71-81.","journal-title":"J Am Stat Assoc"},{"issue":"5","key":"7701_CR35","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/ijerph5050394","volume":"5","author":"JT Efird","year":"2008","unstructured":"Efird JT, Nielsen SS. A method to compute multiplicity corrected confidence intervals for odds ratios and other relative effect estimates. Int J Environ Res Public Health 2008;5(5):394-8.","journal-title":"Int J Environ Res Public Health"},{"key":"7701_CR36","doi-asserted-by":"publisher","first-page":"117693512098513","DOI":"10.1177\/1176935120985132","volume":"20","author":"JT Efird","year":"2021","unstructured":"Efird JT. Goldilocks Rounding: achieving balance between accuracy and parsimony in the reporting of relative effect estimates. Cancer Informat 2021;20:1176935120985132.","journal-title":"Cancer Informat"},{"issue":"1","key":"7701_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7326\/M20-2911","volume":"174","author":"M Jalili","year":"2021","unstructured":"Jalili M, et al. Characteristics and Mortality of Hospitalized Patients With COVID-19 in Iran: A National Retrospective Cohort Study. Ann Intern Med 2021;174(1):125-7.","journal-title":"Ann Intern Med"},{"key":"7701_CR38","doi-asserted-by":"publisher","first-page":"m1966","DOI":"10.1136\/bmj.m1966","volume":"369","author":"CM Petrilli","year":"2020","unstructured":"Petrilli CM, Jones SA, Yang J, Rajagopalan H, O\u2019Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966.","journal-title":"BMJ."},{"issue":"7821","key":"7701_CR39","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-6.","journal-title":"Nature."},{"issue":"6","key":"7701_CR40","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1682\/JRRD.2015.06.0104","volume":"53","author":"T Moin","year":"2016","unstructured":"Moin T, Damschroder LJ, Youles B, Makki F, Billington C, Yancy W, et al. Implementation of a prediabetes identification algorithm for overweight and obese Veterans. J Rehabil Res Dev 2016;53(6):853-62.","journal-title":"J Rehabil Res Dev"},{"issue":"Suppl 1","key":"7701_CR41","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.2337\/dc18-S009","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. Cardiovascular disease and risk management: standards of medical care in diabetes-2018. Diabetes Care 2018;41(Suppl 1):S86-s104.","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"7701_CR42","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.2337\/dc18-S008","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018. Diabetes Care 2018;41(Suppl 1):S73-s85.","journal-title":"Diabetes Care"},{"key":"7701_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.biopha.2016.04.043","volume":"82","author":"F Kong","year":"2016","unstructured":"Kong F, Ye B, Lin L, Cai X, Huang W, Huang Z. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4\/MyD88\/NF-\u03baB signaling in PMA-stimulated THP-1 monocytes. Biomed Pharmacother 2016;82:167-72.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"7701_CR44","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1055\/s-0040-1713152","volume":"120","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, et al. Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thromb Haemost 2020;120(7):1004-24.","journal-title":"Thromb Haemost"},{"issue":"6","key":"7701_CR45","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.diabet.2020.07.006","volume":"46","author":"AJ Scheen","year":"2020","unstructured":"Scheen AJ. Metformin and COVID-19: from cellular mechanisms to reduced mortality. Diabetes Metab 2020;46(6):423-6.","journal-title":"Diabetes Metab"},{"issue":"10","key":"7701_CR46","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.2337\/dc20-1205","volume":"43","author":"B Cariou","year":"2020","unstructured":"Cariou B, Hadjadj S, Wargny M, Pichelin M, Gourdy P. Comment on Chen et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care 2020;43:1399-1407. Diabetes Care 2020;43(10):e163-e164.","journal-title":"Diabetes Care"},{"issue":"1","key":"7701_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4269\/ajtmh.20-0375","volume":"103","author":"P Luo","year":"2020","unstructured":"Luo P, Qiu L, Liu Y, Liu XL, Zheng JL, Xue HY, et al. Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis. Am J Trop Med Hyg 2020;103(1):69-72.","journal-title":"Am J Trop Med Hyg"},{"issue":"1081","key":"7701_CR48","doi-asserted-by":"publisher","first-page":"600439","DOI":"10.3389\/fendo.2020.600439","volume":"11","author":"AB Crouse","year":"2021","unstructured":"Crouse AB, Grimes T, Li P, Might M, Ovalle F, Shalev A. Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes. Front Endocrinol 2021;11(1081):600439.","journal-title":"Front Endocrinol"},{"issue":"625","key":"7701_CR49","doi-asserted-by":"publisher","first-page":"587801","DOI":"10.3389\/fendo.2021.587801","volume":"12","author":"S Ibrahim","year":"2021","unstructured":"Ibrahim S, Lowe JR, Bramante CT, Shah S, Klatt NR, Sherwood N, et al. Metformin and Covid-19: focused review of mechanisms and current literature suggesting benefit. Front Endocrinol 2021;12(625):587801.","journal-title":"Front Endocrinol"},{"key":"7701_CR50","doi-asserted-by":"crossref","unstructured":"Rose L, Graham L, Koenecke A, Powell M, Xiong R, Shen Z, et al. The association between Alpha-1 adrenergic receptor antagonists and in-hospital mortality from COVID-19. Front Med. 2021;8(304).","DOI":"10.3389\/fmed.2021.637647"},{"issue":"12","key":"7701_CR51","first-page":"e20691","volume":"13","author":"FA Cadegiani","year":"2021","unstructured":"Cadegiani FA, Zimerman RA, Fonseca DN, Correia MN, Muller MP, Bet DL, et al. Efficacy of proxalutamide in hospitalized COVID-19 patients: a randomized, double-blind, placebo-controlled, parallel-design clinical trial. Cureus. 2021;13(12):e20691.","journal-title":"Cureus."},{"issue":"8","key":"7701_CR52","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S2213-2600(21)00222-8","volume":"9","author":"JC Tardif","year":"2021","unstructured":"Tardif JC, Bouabdallaoui N, L'Allier PL, Gaudet D, Shah B, Pillinger MH, et al. Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir Med 2021;9(8):924\u2013932.","journal-title":"Lancet Respir Med"},{"key":"7701_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbrc.2020.11.095","volume":"538","author":"LR Reznikov","year":"2021","unstructured":"Reznikov LR, Norris MH, Vashisht R, Bluhm AP, Li D, Liao YJ, et al. Identification of antiviral antihistamines for COVID-19 repurposing. Biochem Biophys Res Commun 2021;538:173-9.","journal-title":"Biochem Biophys Res Commun"},{"key":"7701_CR54","unstructured":"NCT04583410. Efficacy of Nicotine in Preventing COVID-19 Infection (NICOVID-PREV). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04583410 Accessed on March 12 2021."},{"key":"7701_CR55","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.toxrep.2020.04.012","volume":"7","author":"K Farsalinos","year":"2020","unstructured":"Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis A, Kouretas D, et al. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicol Rep 2020;7:658-63.","journal-title":"Toxicol Rep"},{"issue":"1","key":"7701_CR56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/1547691X.2021.1875085","volume":"18","author":"AG Gauthier","year":"2021","unstructured":"Gauthier AG, Lin M, Wu J, Kennedy TP, Daley L-A, Ashby CR, et al. From nicotine to the cholinergic anti-inflammatory reflex \u2013 Can nicotine alleviate the dysregulated inflammation in COVID-19? J Immunotoxicol 2021;18(1):23-9.","journal-title":"J Immunotoxicol"},{"key":"7701_CR57","unstructured":"US Department of Veterans Affairs. Available at https:\/\/www.va.gov\/health\/docs\/VA_COVID_Response.pdf Accessed on July 20 2021."},{"key":"7701_CR58","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/PPA.S74531","volume":"9","author":"HJ Weidenbacher","year":"2015","unstructured":"Weidenbacher HJ, Beadles CA, Maciejewski ML, Reeve BB, Voils CI. Extent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: the association with depressive symptom burden in a sample of American veterans. Patient Prefer Adherence 2015;9:327-36.","journal-title":"Patient Prefer Adherence"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07701-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-022-07701-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07701-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T02:39:09Z","timestamp":1727491149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-022-07701-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":58,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7701"],"URL":"https:\/\/doi.org\/10.1007\/s11606-022-07701-3","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Hunt is a consultant to Akebia Therapeutics, Inc. Dr. Hostler is co-owner of Infection Control Education for Major Sports, LLC, and consultant for OneBeacon Insurance and Prime Education, LLC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}